Aptose Biosciences Inc.
NASDAQ:APTO
1.71 (USD) • At close April 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.042 | 0.058 | 0.124 | 0.169 | 0.043 | 0.1 | 0 | 0.005 | 0.447 | 0.048 | 0 | 0.001 | 0.001 | 0.068 | 0.069 | 0.073 |
| Cost of Revenue
| 0 | 0.475 | 0.507 | 0.617 | 0.646 | 0.627 | 0.084 | 0.089 | 0.115 | 0.069 | 0 | 0 | 0 | 0.042 | 0.058 | 0 | 0 | 0.002 | 0.016 | 0.003 | 0.001 | 1.608 | 0.04 | 0 | -1.171 | -0.946 | -0.203 | -0.069 | 0 |
| Gross Profit
| 0 | -0.475 | -0.507 | -0.617 | -0.646 | -0.627 | -0.084 | -0.089 | -0.115 | -0.069 | 0 | 0 | 0 | 0 | 0 | 0.124 | 0.169 | 0.041 | 0.084 | -0.003 | 0.004 | -1.161 | 0.008 | 0 | 1.172 | 0.946 | 0.271 | 0.137 | 0.073 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0.953 | 0.84 | -498.977 | 0.8 | -2.599 | 0.167 | 0 | 1,171.631 | 1,417.999 | 4 | 2 | 1 |
| Reseach & Development Expenses
| 15.103 | 36.765 | 28.088 | 45.985 | 29.288 | 16.835 | 18.733 | 6.274 | 7.662 | 4.481 | 0.004 | 2.779 | 3.177 | 1.932 | 2.352 | 2.399 | 3.757 | 6.126 | 3.164 | 9.297 | 11.47 | 19.661 | 9.144 | 5.666 | 6.372 | 2.832 | 2.17 | 1.922 | 2.104 |
| General & Administrative Expenses
| 11.154 | 15.591 | 14.514 | 19.462 | 26.48 | 10.022 | 10.374 | 5.502 | 6.128 | 7.046 | 0.008 | 6.071 | 2.2 | 2.489 | 2.689 | 2.976 | 3.123 | 3.888 | 3.848 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0.053 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.745 | 0.22 | 5.026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11.154 | 15.591 | 14.514 | 19.462 | 26.48 | 10.022 | 10.374 | 5.502 | 6.128 | 7.046 | 0.008 | 6.071 | 2.2 | 2.489 | 2.689 | 2.976 | 3.123 | 4.633 | 4.068 | 5.031 | 5.381 | 3.608 | 3.617 | 3.185 | 4.172 | 2.437 | 1.153 | 1.304 | 1.088 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0.057 | 0 | 0 | 0.319 | 0.479 | 0.779 | 0 | 0 | -12.753 | 1.28 | 2.408 | 1.777 | 0.203 | 0.275 | 0.363 |
| Operating Expenses
| 26.257 | 52.356 | 42.602 | 65.447 | 55.768 | 26.857 | 29.107 | 11.826 | 13.804 | 11.52 | 0.012 | 8.855 | 5.371 | 4.443 | 5.099 | 5.443 | 6.743 | 11.075 | 7.711 | 15.107 | 0.004 | 23.576 | 0.008 | 10.131 | 1.172 | 0.946 | 0.204 | 0.137 | 3.555 |
| Operating Income
| 0 | -52.356 | -42.602 | -65.447 | -55.768 | -26.857 | -29.107 | -11.826 | -13.887 | -11.601 | -0.012 | -8.855 | -5.423 | -4.464 | -5.099 | -5.319 | -6.574 | -11.033 | -7.626 | -15.086 | -17.421 | -23.15 | 13.009 | -10.131 | -11.78 | -6.1 | -3.323 | -3.364 | -3.483 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -105.086 | -88.219 | -42.84 | -38.946 | -256.442 | -76.24 | -2,514,399.588 | -3,484.855 | -51.826 | 272.024 | 0 | -11,776.287 | -9,140 | -48.99 | -49 | -48 |
| Total Other Income Expenses Net
| 0 | 1.149 | 0.779 | 0.093 | 0.53 | 0.58 | 0.239 | 0.165 | 0.029 | 1.061 | -11.492 | -0.871 | 0.023 | -0.014 | -0.057 | 10.371 | 6.574 | 11.033 | -1.389 | -1.179 | 17.421 | 0.909 | -13.009 | 1.306 | 11.78 | 6.1 | 3.323 | 3.364 | 3.483 |
| Income Before Tax
| -25.43 | -51.207 | -41.823 | -65.354 | -55.238 | -26.277 | -28.868 | -11.661 | -13.858 | -10.54 | -11.503 | -9.726 | -5.399 | -4.478 | -5.156 | 5.053 | -0 | 0 | -9.015 | -16.265 | -0 | -22.241 | -0 | -8.825 | -0 | -0 | -0 | -0 | -0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -105.406 | -89.197 | 40.695 | -0 | 0.001 | -90.13 | -2,710,904.894 | -0 | -49.79 | -0 | 0 | -0 | -0.001 | -0 | -0 | -0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.018 | 0.032 | 0.031 | -0 | 0.239 | -5.394 | -0.023 | -0.002 | -5.053 | 8.128 | 6.37 | -0.003 | 16.265 | 17.582 | 0 | 12.119 | 8.825 | 9.895 | 5.739 | 3.12 | 3.227 | 3.483 |
| Net Income
| -25.43 | -51.207 | -41.823 | -65.354 | -55.238 | -26.277 | -28.868 | -11.661 | -13.858 | -10.54 | -0.012 | -9.726 | -5.399 | -4.478 | -5.156 | 5.08 | -8.085 | -6.374 | -9.015 | -16.267 | -17.582 | -22.241 | -12.119 | -8.825 | -9.895 | -5.739 | -3.12 | -3.227 | -3.483 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -105.406 | -89.197 | 40.919 | -47.897 | -148.157 | -90.13 | -2,711,143.333 | -3,517.053 | -49.79 | -253.42 | 0 | -9,891.882 | -8,599 | -46 | -47 | -48 |
| EPS
| -0.036 | -7.58 | -6.67 | -10.99 | -10.03 | -7.8 | -12.97 | -7.84 | -16.32 | -13.29 | -0.015 | -12.58 | -23 | -38.27 | -92.1 | 97.24 | -177.65 | -159.94 | -237.56 | -506.19 | -551.63 | -699.79 | -452.63 | -332.17 | -379.57 | -360.4 | -445.04 | -481.96 | -626.97 |
| EPS Diluted
| -0.036 | -7.58 | -6.67 | -10.99 | -10.03 | -7.8 | -12.97 | -7.84 | -16.31 | -13.28 | -0.015 | -12.57 | -23 | -38.15 | -91.64 | 97.24 | -177.65 | -159.94 | -237.56 | -506.19 | -551.63 | -699.79 | -452.63 | -332.17 | -379.57 | -360.4 | -445.04 | -481.96 | -626.97 |
| EBITDA
| 0 | -52.268 | -42.482 | -65.297 | -55.616 | -26.261 | -29.02 | -11.742 | -13.775 | -10.429 | -11.73 | -9.461 | -5.342 | -4.393 | -5.025 | -5.639 | -5.71 | -10.714 | -6.535 | -12.769 | -15.553 | -21.56 | 14.49 | -7.708 | -9.372 | -4.323 | -2.983 | -3.089 | -3.12 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -103.41 | -86.929 | -45.419 | -33.826 | -249.031 | -65.33 | -2,128,162 | -3,111.27 | -48.266 | 303.004 | 0 | -9,369.046 | -6,478 | -43.99 | -45 | -43 |